Menopause

Menopause is the natural, permanent end of menstrual periods, confirmed once a woman has gone 12 consecutive months without a period. It marks the close of the reproductive years and is driven by a normal age-related decline in ovarian hormone production — not a disease, but a life transition that can bring symptoms worth understanding and, when bothersome, treating.

What is menopause?

Menopause is defined clinically as the point in time 12 months after a woman's final menstrual period (FMP), reflecting the permanent loss of ovarian follicular activity (StatPearls). It is diagnosed retrospectively — you only know the FMP has happened once a full year of amenorrhea has passed.

It helps to separate three distinct stages:

• Perimenopause (the menopausal transition): The years leading up to menopause, usually beginning in the mid-40s, when ovarian hormone output becomes erratic and periods grow irregular. This stage can last several years and is when symptoms are often most pronounced (ACOG, Cleveland Clinic).
• Menopause: The single point marking 12 months without a period. In the United States the average age is about 51, with a typical range of 45 to 55 (StatPearls, ACOG).
• Postmenopause: All the years after menopause. Some symptoms ease, while long-term considerations such as bone and cardiovascular health become more important.

The relevant ICD-10 codes include N95.1 (menopausal and female climacteric states) and E28.310 (symptomatic premature menopause). When menopause-related vaginal changes are the focus, N95.2 (postmenopausal atrophic vaginitis) is often used.

A related but distinct condition is primary ovarian insufficiency (POI), also called premature ovarian insufficiency — loss of normal ovarian function before age 40. Unlike menopause, women with POI may still have intermittent periods and occasionally ovulate, so pregnancy remains possible in some cases (NIH).

What causes it and who's at risk?

Menopause is caused by the natural depletion of ovarian follicles. A woman is born with a finite number of eggs; over decades this reserve falls, the ovaries make progressively less estrogen and progesterone, and ovulation eventually stops. As the ovaries become less responsive, the pituitary gland produces more follicle-stimulating hormone (FSH) in an attempt to stimulate them — which is why FSH rises after menopause (StatPearls).

Every woman who lives long enough will reach menopause. The factors below mostly influence *timing* or the likelihood of an earlier or induced menopause:

• Age: The single largest factor; natural menopause clusters around age 45–55.
• Smoking: Among the most consistently documented influences — women who smoke tend to reach menopause about a year earlier than non-smokers, and current smokers have roughly double the risk of premature or early menopause, with a dose-response relationship (PMID 30481189).
• Surgery (induced menopause): Removal of both ovaries (bilateral oophorectomy) causes immediate surgical menopause. Hysterectomy that preserves the ovaries ends periods but may bring menopause forward.
• Cancer treatment: Chemotherapy and pelvic radiation can damage ovarian tissue and trigger early, premature, or induced menopause (PMID 37802711).
• Genetics and family history: The age your mother reached menopause is a partial predictor; certain genetic conditions (such as Turner syndrome or *FMR1* premutations) and autoimmune disorders raise the risk of POI.

Premature menopause (before age 40) and early menopause (ages 40–44) are less common than menopause at the typical age. These earlier transitions deserve medical attention because a longer span of low estrogen can increase long-term risks to bone and heart health (NIH).

What are the symptoms?

Symptoms arise mainly from declining and fluctuating estrogen. They vary widely — some women have few symptoms, others find them significantly disruptive. Common features include:

• Irregular periods: Usually the first sign during perimenopause — cycles become shorter, longer, lighter, or heavier before stopping.
• Vasomotor symptoms (VMS): Hot flashes and night sweats are the hallmark symptoms, caused by changes in the brain's temperature-regulating center. They are among the most common reasons women seek treatment.
• Sleep disturbance: Difficulty falling or staying asleep, often worsened by night sweats.
• Mood changes: Irritability, anxiety, low mood, and difficulty concentrating ("brain fog").
• Genitourinary syndrome of menopause (GSM): Vaginal dryness, irritation, painful intercourse, and urinary symptoms such as urgency or recurrent urinary tract infections, resulting from thinning of estrogen-dependent tissues (AUA/SUFU/AUGS). Unlike hot flashes, GSM tends to be progressive and does not improve on its own.
• Other changes: Joint aches, changes in skin and hair, reduced libido, and weight redistribution toward the abdomen.

Hot flashes and night sweats often improve over time, but their duration is individual and can persist for years.

How is menopause diagnosed?

For most women in the expected age range with typical symptoms, menopause is a clinical diagnosis — no blood test is required. The defining criterion is 12 consecutive months without a menstrual period, with no other cause (StatPearls, ACOG).

Routine hormone testing is generally *not* recommended during perimenopause. Because FSH and estradiol fluctuate dramatically from day to day in the transition, a single result is unreliable and a "normal" value does not rule out perimenopause (ACOG). A woman who is still having periods cannot have menopause confirmed by a blood test alone.

Hormone testing can be useful in specific situations:

• Suspected premature/early menopause: In women under 40 (and often 40–45) with menopausal symptoms or absent periods, repeated elevated FSH levels help confirm POI or early menopause (NIH).
• Unclear cause: When pregnancy, thyroid disease, or other conditions need to be excluded. Clinicians commonly check thyroid-stimulating hormone (TSH) and a pregnancy test, since thyroid disorders can mimic menopausal symptoms.
• After hysterectomy with ovaries intact: When there are no periods to track, FSH (sometimes repeated) may help clarify menopausal status.

A clinician will also review the pattern of bleeding and rule out red-flag causes of abnormal bleeding before attributing symptoms to menopause.

How is menopause treated?

Menopause itself needs no treatment. The goal is to relieve bothersome symptoms and protect long-term health. Care is individualized and generally follows a stepped approach.

Lifestyle measures first

For mild symptoms, non-drug strategies are reasonable first steps: regular physical activity, maintaining a healthy weight, limiting alcohol and caffeine, not smoking, dressing in layers and keeping the bedroom cool for hot flashes, and prioritizing sleep. Cognitive behavioral therapy (CBT) has evidence for reducing the impact of hot flashes and improving sleep and mood. Pelvic floor exercises and vaginal moisturizers and lubricants help with genitourinary and sexual symptoms.

Over-the-counter options

Non-hormonal vaginal moisturizers (used regularly) and lubricants (used for intercourse) are effective first-line measures for vaginal dryness and discomfort and are available without a prescription. Evidence for over-the-counter supplements such as black cohosh or soy isoflavones is mixed and inconsistent; they are not reliably effective and should be discussed with a clinician, especially given the lack of long-term safety data.

Prescription options for hot flashes and night sweats

• Menopausal hormone therapy (MHT/HRT): The most effective treatment for vasomotor symptoms and a recognized option for preventing bone loss. It uses estrogen, combined with a progestogen in women who still have a uterus to protect the uterine lining (ACOG, The Menopause Society). For most healthy women under 60 or within 10 years of menopause, the benefits typically outweigh the risks; suitability depends on personal and family history (e.g., breast cancer, blood clots, cardiovascular disease). Therapy is individualized in type, dose, and route (oral vs. transdermal).
• Non-hormonal prescription medications for women who cannot or prefer not to use hormones:
• NK3 / dual neurokinin receptor antagonists: *Fezolinetant* (an NK3 antagonist) is FDA-approved for moderate-to-severe VMS and targets the brain's thermoregulatory pathway directly. *Elinzanetant* (a dual NK1/NK3 antagonist) was FDA-approved in October 2025 as a further hormone-free option (FDA).
• Low-dose paroxetine (an SSRI) is FDA-approved specifically for hot flashes; other SSRIs/SNRIs (e.g., venlafaxine, escitalopram), gabapentin, and clonidine are used off-label with supporting evidence.

Prescription options for genitourinary symptoms

GSM responds well to low-dose vaginal estrogen (cream, tablet, or ring), which acts locally with minimal systemic absorption; in November 2025 the FDA announced the removal of the long-standing boxed warning from estrogen-containing products, including these low-dose vaginal formulations, reflecting their favorable safety profile. Other approved options include ospemifene (an oral selective estrogen receptor modulator) and vaginal prasterone (DHEA) (AUA/SUFU/AUGS, StatPearls).

Can menopause be prevented or managed long-term?

Menopause cannot be prevented or reversed — it is a normal stage of life. The realistic goals are symptom management and protecting health in the decades afterward, when lower estrogen contributes to faster bone loss and shifts in cardiovascular risk.

Long-term management focuses on:

• Bone health: Adequate calcium and vitamin D, weight-bearing and resistance exercise, not smoking, and bone-density (DXA) screening as advised. The U.S. Preventive Services Task Force recommends osteoporosis screening for women 65 and older, and earlier for those at increased risk.
• Heart health: Managing blood pressure, cholesterol, blood sugar, and weight; staying active; and following cardiovascular prevention guidance (AHA).
• Cancer screening: Continuing recommended breast and cervical cancer screening.
• Earlier menopause: Women with premature or early menopause are often advised to use hormone therapy at least until the average age of natural menopause (around 51) unless contraindicated, to offset the longer period of estrogen deficiency (NIH).

When should you see a doctor?

See a clinician if menopausal symptoms interfere with daily life, sleep, mood, work, or relationships — effective treatments exist. Also seek care to discuss whether hormone therapy is appropriate for you.

Certain symptoms are red flags that warrant prompt evaluation because they are not normal parts of menopause and may signal another condition:

• Any vaginal bleeding after menopause (after 12 months without a period) — this always needs evaluation to exclude endometrial cancer and other causes.
• Very heavy bleeding, bleeding between periods, or bleeding after intercourse during perimenopause.
• Periods stopping before age 40, which may indicate primary ovarian insufficiency.
• New or severe symptoms that don't fit menopause, such as significant unexplained weight loss, severe pelvic pain, or breast lumps.

What's the outlook?

The outlook is excellent: menopause is a natural transition, not an illness, and most women navigate it successfully. Hot flashes and night sweats commonly improve over time, though the timeline is individual. Symptoms that respond to treatment can usually be controlled effectively, and women have several safe, evidence-based options to choose from.

The main long-term focus shifts to preventive health — protecting bones and the cardiovascular system and staying current with screening. With attention to lifestyle and appropriate medical care, women can expect to remain healthy and active for the many years of postmenopausal life.

Frequently asked questions

How long do hot flashes last? They vary widely between individuals. Many women experience hot flashes for several years around the menopausal transition, and some have them for longer. If they are disruptive, effective hormonal and non-hormonal treatments are available.

Can I still get pregnant during perimenopause? Yes. Until you have gone 12 full months without a period, ovulation can still occur and pregnancy is possible, so contraception is still needed if you wish to avoid pregnancy. Pregnancy is generally not possible after menopause is confirmed.

Is hormone therapy safe? For most healthy women who start it under age 60 or within about 10 years of menopause, the benefits of hormone therapy for bothersome symptoms typically outweigh the risks (ACOG, The Menopause Society). Safety depends on your personal and family medical history, so the decision should be individualized with your clinician. Low-dose vaginal estrogen for genitourinary symptoms carries minimal systemic absorption and a favorable safety profile.

Do I need a blood test to confirm menopause? Usually not. In women in the typical age range with characteristic symptoms, menopause is diagnosed clinically after 12 months without a period. Hormone testing is mainly reserved for suspected early or premature menopause or when another condition needs to be ruled out (ACOG).

What's the difference between perimenopause and menopause? Perimenopause is the transition phase — often several years — when hormones fluctuate and periods become irregular but have not fully stopped. Menopause is the specific point reached after 12 consecutive months with no period. The years afterward are called postmenopause.

*This page is for general education and is not a substitute for personalized medical advice. Talk with a qualified clinician about your individual situation.*